We have observed
40 EP applications
Michael Antony Reed
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after February 4, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DIHYDROPYRROLO PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
FATTY ACID SYNTHASE INHIBITORS
METHOD OF TREATMENT
METHOD OF TREATING CANCER
METHOD OF ADMINISTRATION AND TREATMENT
TREATMENT METHOD FOR STEROID RESPONSIVE DERMATOSES
Pyridazine-dione N-substituted glycine derivatives as HIF hydroxylase inhibitors
PHARMACEUTICAL COMBINATION OF A VEGFR INHIBITOR AND A MEK INHIBITOR USEFUL FOR TREATING CANCER
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
METHOD OF TREATMENT WITH BRAF INHIBITOR
COMBINATION THERAPY FOR TREATING CANCER
Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
CHEMICAL COMPOUNDS ACTING AS PERK INHIBITORS
NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FOR THE TREATMENT OF E.G. FIBROTIC DISEASES